News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,749 Results
Type
Article (8066)
Company Profile (140)
Press Release (477542)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (167108)
Career Advice (305)
Deals (25790)
Drug Delivery (7)
Drug Development (52880)
Employer Resources (14)
FDA (9789)
Job Trends (8580)
News (238617)
Policy (17942)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33253)
ALS (105)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (263)
Approvals (10406)
Artificial intelligence (321)
ASCO (159)
Autoimmune disease (205)
Automation (33)
Bankruptcy (262)
Best Places to Work (6969)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (508)
Cancer (3650)
Cardiovascular disease (217)
Career advice (247)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (477)
Cervical cancer (34)
Clinical research (47874)
Collaboration (1251)
Commercialization (3)
Compensation (1468)
Complete response letters (34)
COVID-19 (760)
CRISPR (63)
C-suite (748)
Cystic fibrosis (85)
Data (5656)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (343)
Diagnostics (4328)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73873)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87704)
Executive appointments (703)
FDA (12423)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (918)
Gene editing (125)
Generative AI (9)
Gene therapy (319)
GLP-1 (290)
Government (959)
Grass and pollen (2)
Guidances (281)
Healthcare (9401)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (951)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (42)
IPO (12413)
IRA (2)
Job creations (1972)
Job search strategy (236)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5215)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (251)
Machine learning (27)
Management (3)
Manufacturing (535)
Marketing (8)
MASH (118)
Medical device (8664)
Medtech (8809)
Mergers & acquisitions (14413)
Metabolic disorders (706)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1824)
NextGen: Class of 2026 (3156)
Non-profit (846)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (172)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (507)
Peanut (31)
People (41327)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15470)
Phase 2 (21379)
Phase 3 (14404)
Pipeline (7347)
Policy (18)
Postmarket research (1572)
Preclinical (6541)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (571)
Real estate (3028)
Recruiting (6)
Regulatory (14870)
Reports (21)
Research institute (587)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2032)
Stomach cancer (3)
Supply chain (50)
Vaccines (322)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Last 7 days (219)
Last 30 days (1596)
Last 365 days (19040)
2026 (12328)
2025 (19286)
2024 (23040)
2023 (26598)
2022 (34705)
2021 (37278)
2020 (33566)
2019 (23331)
2018 (17545)
2017 (18824)
2016 (17969)
2015 (24306)
2014 (21722)
2013 (18173)
2012 (20251)
2011 (20473)
2010 (20358)
Location
Africa (229)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17928)
Australia (2110)
California (11969)
Canada (3148)
China (524)
Colorado (484)
Connecticut (409)
Delaware (209)
Europe (25399)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (699)
India (51)
Indiana (314)
Iowa (15)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1220)
Massachusetts (7852)
Michigan (308)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2620)
New Mexico (12)
New York (2823)
North Carolina (1278)
North Dakota (4)
Northern California (5995)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4971)
Tennessee (120)
Texas (1940)
United States (38893)
Utah (360)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (936)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
485,749 Results for "qiagen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel
August 10, 2026
·
7 min read
Press Releases
QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe
July 15, 2026
·
7 min read
Press Releases
QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast
July 16, 2026
·
1 min read
Press Releases
QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook
August 5, 2026
·
8 min read
Press Releases
QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak
July 16, 2026
·
6 min read
Press Releases
QIAGEN Reports Full Results for Q1 2026
May 7, 2026
·
9 min read
Press Releases
QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak
May 29, 2026
·
7 min read
Press Releases
QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma
June 15, 2026
·
8 min read
Press Releases
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
May 21, 2026
·
7 min read
Press Releases
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
May 20, 2026
·
7 min read
1 of 48,575
Next
